Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer-Reference-Cited by-同舟云学术

Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer

Published:2002 Issue:3 Volume:38 Page:327-332
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Jakesz R,Hausmaninger H,Samonigg H

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Tamoxifen for early breast cancer;Lancet,1998

2. Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma;Lancet,1993

3. Jonat W. Zoladex™ (goserelin) vs. CMF as adjuvant therapy in pre-/perimenopausal node-positive breast cancer: preliminary efficacy results from the ZEBRA Study. Eur J Cancer 2000, 36 (suppl 5), S67 (abstr 132).

4. Premenopausal oophorectomy versus CMF chemotherapy in stage II breast cancer. International Breast Cancer Study Group;Gelber;Lancet,1993

5. Endocrine therapy, chemotherapy, or both as adjuvant systemic treatment of patients with early breast cancer;Henderson;Am. Soc. Clin. Oncol. Educat. Book,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a novel recombinant LHRH fusion protein for therapy of androgen and estrogen dependent cancers;Protein Expression and Purification;2017-06

2. Same gain, less pain: potential patient preferences for adjuvant treatment in premenopausal women with early breast cancer;European Journal of Cancer;2004-11

3. Bone Mineral Density Among Premenopausal Women With Early Breast Cancer in a Randomized Trial of Adjuvant Endocrine Therapy;Journal of Clinical Oncology;2004-09-15

4. Current limits of knowledge in adjuvant and neoadjuvant endocrine therapy of breast cancer: the need for more clinical research;Surgical Oncology;2003-12

5. CORRESPONDENCE;Journal of Clinical Oncology;2003-06-15